Pfizer Inc. logo
Pfizer Inc. (PFE)
Compare

Pfizer Inc. (PFE) Earnings Yield: 5.11%

Is Pfizer Inc.’s earnings yield high or low?

Pfizer Inc.'s earnings yield of 5.11% is 31% below its 5-year average of 7.46%, near the low end of its 5-year range (1.25%–14.49%).

The earnings yield for Pfizer Inc. (PFE) is 5.11% as of Wednesday, June 10, 2026. It is below its 12-month average by 18.64% (6.28%).

PFE Earnings Yield Chart

PFE Earnings Yield
5.11%-10.04% 1Y
Zoom

PFE Average Earnings Yield Chart

PFE Current vs Average Earnings Yield Chart

PFE Earnings Yield Metrics

EARNINGS YIELD

5.11%

EARNINGS YIELD AVG TTM

6.28%

EARNINGS YIELD AVG 3Y

6.38%

EARNINGS YIELD AVG 5Y

7.46%

EARNINGS YIELD AVG 10Y

6.76%

EARNINGS YIELD AVG 15Y

6.78%

EARNINGS YIELD AVG 20Y

7.02%

CURRENT VS TTM AVG

-18.64%

CURRENT VS 3Y AVG

-19.94%

CURRENT VS 5Y AVG

-31.48%

CURRENT VS 10Y AVG

-24.45%

CURRENT VS 15Y AVG

-24.61%

CURRENT VS 20Y AVG

-27.25%

PFE Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
Pfizer Inc. (PFE)5.11%6.28%6.38%7.46%
Intuitive Surgical, Inc. (ISRG)$146.44B1.99%1.54%1.36%1.43%
Gilead Sciences, Inc. (GILD)$151.21B6.03%4.73%3.68%4.37%
Abbott Laboratories (ABT)$154.66B4.04%5.50%4.05%3.87%
Danaher Corporation (DHR)$130.25B2.80%2.43%2.72%3.03%
CVS Health Corporation (CVS)$125.16B2.31%2.92%5.90%5.70%
Bristol-Myers Squibb Company (BMY)$114.14B6.37%5.69%6.24%5.43%
Thermo Fisher Scientific Inc. (TMO)$179.45B3.77%3.47%3.14%3.26%
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B3.86%3.40%3.43%3.73%
Amgen Inc. (AMGN)$183.75B4.22%4.01%3.83%4.18%

Earnings Yield vs P/E Ratio

Earnings Yield

5.11%

EPS ÷ Price

P/E Ratio

19.6

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

Pfizer Inc. Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Pfizer Inc. Earnings Yield FAQ

What is the earnings yield for Pfizer Inc. (PFE)?
The earnings yield for PFE stock is 5.11%.
Is Pfizer Inc.'s earnings yield high or low?
Pfizer Inc.'s earnings yield of 5.11% is 31% below its 5-year average of 7.46%, near the low end of its 5-year range (1.25%–14.49%).
What is the TTM average earnings yield for Pfizer Inc. (PFE)?
The TTM average earnings yield for PFE stock is 6.28%.
What is the 3Y average earnings yield for Pfizer Inc. (PFE)?
The 3Y average earnings yield for PFE stock is 6.38%.
What is the 5Y average earnings yield for Pfizer Inc. (PFE)?
The 5Y average earnings yield for PFE stock is 7.46%.
What is the 10Y average earnings yield for Pfizer Inc. (PFE)?
The 10Y average earnings yield for PFE stock is 6.76%.
What is the 15Y average earnings yield for Pfizer Inc. (PFE)?
The 15Y average earnings yield for PFE stock is 6.78%.
What is the 20Y average earnings yield for Pfizer Inc. (PFE)?
The 20Y average earnings yield for PFE stock is 7.02%.

Pfizer Inc. Earnings Yield History

DATEEARNINGS YIELD
2026-06-105.11%
2026-06-095.10%
2026-06-085.11%
2026-06-055.03%
2026-06-045.10%
2026-06-035.17%
2026-06-025.13%
2026-06-015.11%
2026-05-295.01%
2026-05-285.01%
2026-05-275.00%
2026-05-265.07%
2026-05-225.06%
2026-05-215.05%
2026-05-205.08%
2026-05-195.10%
2026-05-185.17%
2026-05-155.17%
2026-05-145.09%
2026-05-135.05%
2026-05-125.06%
2026-05-115.08%
2026-05-085.10%
2026-05-074.95%
2026-05-064.94%
2026-05-054.95%
2026-05-045.17%
2026-05-015.16%
2026-04-305.09%
2026-04-295.18%
2026-04-285.13%
2026-04-275.08%
2026-04-245.04%
2026-04-235.10%
2026-04-225.07%
2026-04-214.98%
2026-04-204.94%
2026-04-174.93%
2026-04-165.00%
2026-04-155.00%
2026-04-145.02%
2026-04-134.97%
2026-04-105.05%
2026-04-095.00%
2026-04-084.95%
2026-04-075.02%
2026-04-064.89%
2026-04-024.80%
2026-04-014.76%
2026-03-314.84%
2026-03-304.89%
2026-03-275.03%
2026-03-264.93%
2026-03-254.99%
2026-03-245.04%
2026-03-235.08%
2026-03-205.04%
2026-03-194.96%
2026-03-184.98%
2026-03-174.95%
2026-03-165.11%
2026-03-135.12%
2026-03-125.06%
2026-03-114.98%
2026-03-105.01%
2026-03-095.07%
2026-03-065.03%
2026-03-055.11%
2026-03-045.11%
2026-03-035.12%
2026-03-024.99%
2026-02-274.92%
2026-02-265.02%
2026-02-256.35%
2026-02-246.34%
2026-02-236.36%
2026-02-206.46%
2026-02-196.41%
2026-02-186.29%
2026-02-176.29%
2026-02-136.24%
2026-02-126.27%
2026-02-116.21%
2026-02-106.23%
2026-02-096.37%
2026-02-066.33%
2026-02-056.50%
2026-02-046.43%
2026-02-036.68%
2026-02-026.46%
2026-01-306.51%
2026-01-296.60%
2026-01-286.66%
2026-01-276.50%
2026-01-266.65%
2026-01-236.71%
2026-01-226.60%
2026-01-216.65%
2026-01-206.75%
2026-01-166.71%
2026-01-156.65%
2026-01-146.73%
2026-01-136.84%
2026-01-126.81%
2026-01-096.76%
2026-01-086.81%
2026-01-076.81%
2026-01-066.77%
2026-01-056.84%
2026-01-026.84%
2025-12-316.92%
2025-12-306.89%
2025-12-296.89%
2025-12-266.86%
2025-12-246.88%
2025-12-236.92%
2025-12-226.83%
2025-12-196.84%
2025-12-186.87%
2025-12-176.87%
2025-12-166.74%
2025-12-156.51%
2025-12-126.66%
2025-12-116.67%
2025-12-106.68%
2025-12-096.80%
2025-12-086.68%
2025-12-056.61%
2025-12-046.70%
2025-12-036.73%
2025-12-026.84%
2025-12-016.81%
2025-11-286.69%
2025-11-266.70%
2025-11-256.69%
2025-11-246.83%
2025-11-216.87%
2025-11-207.06%
2025-11-196.92%
2025-11-186.77%
2025-11-176.86%
2025-11-146.87%
2025-11-136.68%
2025-11-126.65%
2025-11-116.75%
2025-11-107.06%
2025-11-077.05%
2025-11-066.93%
2025-11-056.99%
2025-11-047.08%
2025-11-037.65%
2025-10-317.65%
2025-10-307.76%
2025-10-297.76%
2025-10-287.70%
2025-10-277.61%
2025-10-247.62%
2025-10-237.65%
2025-10-227.63%
2025-10-217.59%
2025-10-207.64%
2025-10-177.69%
2025-10-167.78%
2025-10-157.73%
2025-10-147.69%
2025-10-137.62%
2025-10-107.61%
2025-10-097.47%
2025-10-087.34%
2025-10-077.18%
2025-10-067.13%
2025-10-036.89%
2025-10-026.96%
2025-10-016.93%
2025-09-307.40%
2025-09-297.91%
2025-09-267.94%
2025-09-257.99%
2025-09-247.82%
2025-09-237.81%
2025-09-227.84%
2025-09-197.85%
2025-09-187.81%
2025-09-177.84%
2025-09-167.89%
2025-09-157.87%
2025-09-127.90%
2025-09-117.59%
2025-09-107.67%
2025-09-097.63%
2025-09-087.68%
2025-09-057.58%
2025-09-047.68%
2025-09-037.60%
2025-09-027.55%
2025-08-297.62%
2025-08-287.66%
2025-08-277.52%
2025-08-267.56%
2025-08-257.50%
2025-08-227.28%
2025-08-217.33%
2025-08-207.43%
2025-08-197.45%
2025-08-187.52%
2025-08-157.50%
2025-08-147.51%
2025-08-137.50%
2025-08-127.65%
2025-08-117.67%
2025-08-087.67%
2025-08-077.78%
2025-08-067.88%
2025-08-057.62%
2025-08-045.87%
2025-08-015.87%
2025-07-315.92%
2025-07-305.79%
2025-07-295.68%
2025-07-285.68%
2025-07-255.56%
2025-07-245.44%
2025-07-235.44%
2025-07-225.49%
2025-07-215.69%
2025-07-185.64%
2025-07-175.61%
2025-07-165.61%
2025-07-155.61%
2025-07-145.44%
2025-07-115.38%
2025-07-105.35%
2025-07-095.40%
2025-07-085.39%
2025-07-075.47%
2025-07-035.43%
2025-07-025.45%
2025-07-015.51%
2025-06-305.69%
2025-06-275.70%
2025-06-265.69%
2025-06-255.69%
2025-06-245.68%
2025-06-235.74%
2025-06-205.76%
2025-06-185.78%
2025-06-175.75%
2025-06-165.65%
2025-06-135.62%
2025-06-125.56%
2025-06-115.64%
2025-06-105.68%
2025-06-095.76%
2025-06-065.91%
2025-06-055.97%
2025-06-045.90%
2025-06-035.91%
2025-06-025.88%
2025-05-305.87%
2025-05-295.88%

Showing the most recent 260 of 4,907 data points. The chart above shows the full history.

About Pfizer Inc.

Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.

New York City, NY
81,000 employees
Healthcare / Drug Manufacturers - General
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Albert Bourla